Dibenzo[b,f][1,4]oxazepin-11(10H)-one, 95.0%, 250mg

3,6-Difluoro-pyridazine, 95.0%, 5g

2,3-Dibromonorbornadiene, 98%, 5g

(2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol with methanesulfonate, 97.0%, 5g

O-[(Ethoxycarbonyl)cyanomethylenamino]-N,N,N',N'-tetramethyluronium Hexafluorophosphate>98.0%(HPLC)(N)5g

3-[N-Tris(hydroxymethyl)methylamino]-2-hydroxypropanesulfonic Acid [Good's buffer component for biological research]>99.0%(T)25g

3-Chloro-5-(trifluoromethyl)pyridazine, 95.0%, 5g

butyl[(3-phenoxyphenyl)methyl]amine hydrochloride, 95.0%, 2g

4-Methoxy-2,3,5,6-tetrafluorobenzoic acid, 98.0%, 250mg

1,2-Diphenylethyne, 95.0%, 100g

5-(tert-Butyl)nicotinic acid, 95.0%, 1g

2-Hexyn-1-ol, 95.0%, 1g

alpha,alpha,alpha',alpha'-Tetrabromo-p-xylene>98.0%(GC)5g